HK Stock MarketDetailed Quotes

5100 XIZANG (01115)

Watchlist
  • 0.490
  • -0.020-3.92%
Market Closed May 21 16:05 CST
2.76BMarket Cap28.82P/E (TTM)

5100 XIZANG (01115) Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax
116.42%93.99M
----
-65.02%-572.46M
----
-257.21%-346.91M
----
-267.81%-97.12M
----
66.67%57.87M
----
Profit adjustment
Interest (income) - adjustment
-19.36%-37.33M
----
16.58%-31.27M
----
-6.49%-37.49M
----
37.31%-35.2M
----
-4,353.13%-56.15M
----
Dividend (income)- adjustment
---707K
----
----
----
----
----
----
----
----
----
Investment loss (gain)
-99.46%2.56M
----
80.19%471.04M
----
2,344.44%261.41M
----
133,775.00%10.69M
----
-100.38%-8K
----
Impairment and provisions:
-89.67%5.04M
----
30.39%48.74M
----
-58.14%37.38M
----
62.80%89.29M
----
444.57%54.85M
----
-Impairmen of inventory (reversal)
----
----
131.88%1.01M
----
-35.41%436K
----
10.29%675K
----
551.06%612K
----
-Other impairments and provisions
-89.45%5.04M
----
29.19%47.73M
----
-58.31%36.94M
----
63.39%88.62M
----
438.72%54.24M
----
Revaluation surplus:
---764K
----
----
----
----
----
-78.98%2M
----
1,273.49%9.52M
----
-Derivative financial instruments fair value (increase)
--8.44M
----
----
----
----
----
----
----
----
----
-Other fair value changes
---9.2M
----
----
----
----
----
-78.98%2M
----
1,273.49%9.52M
----
Asset sale loss (gain):
100.15%25K
----
-13,096.85%-16.76M
----
92.87%-127K
----
80.58%-1.78M
----
26.05%-9.17M
----
-Loss (gain) from sale of subsidiary company
----
----
---16.52M
----
----
----
---1.78M
----
----
----
-Loss (gain) on sale of property, machinery and equipment
110.59%25K
----
-85.83%-236K
----
---127K
----
----
----
-73.03%24K
----
-Loss (gain) from selling other assets
----
----
----
----
----
----
----
----
26.38%-9.19M
----
Depreciation and amortization:
-8.91%32.91M
----
-38.81%36.13M
----
-1.61%59.04M
----
-16.61%60.01M
----
-13.08%71.96M
----
-Amortization of intangible assets
0.06%3.2M
----
-0.47%3.2M
----
-0.59%3.21M
----
-75.47%3.23M
----
-40.48%13.17M
----
Financial expense
15.21%40.42M
----
-11.42%35.08M
----
5.22%39.6M
----
5.57%37.64M
----
-21.43%35.66M
----
Exchange Loss (gain)
-231.03%-11.25M
----
--8.59M
----
----
----
----
----
----
----
Special items
--20.12M
----
----
----
----
----
--43K
----
----
----
Operating profit before the change of operating capital
718.71%144.1M
----
-321.22%-23.29M
----
-83.34%10.53M
----
-61.02%63.2M
----
22.63%162.15M
----
Change of operating capital
Inventory (increase) decrease
-123.22%-10.53M
----
458.91%45.32M
----
24.03%-12.63M
----
46.27%-16.62M
----
-304.72%-30.94M
----
Accounts receivable (increase)decrease
-1,917.49%-78.26M
----
128.55%4.31M
----
32.92%-15.08M
----
54.92%-22.49M
----
-764.60%-49.88M
----
Accounts payable increase (decrease)
107.87%50.73M
----
120.13%24.4M
----
-480.34%-121.24M
----
-110.18%-20.89M
----
1,608.10%205.21M
----
prepayments (increase)decrease
-35.62%49.79M
----
208.67%77.35M
----
-165.02%-71.18M
----
128.30%109.47M
----
-1,080.44%-386.84M
----
Special items for working capital changes
-150.38%-91.2M
----
302.07%181.05M
----
-344.18%-89.6M
----
-113.38%-20.17M
----
1,300.56%150.73M
----
Cash  from business operations
-79.09%64.63M
-138.32%-20.29M
203.32%309.14M
206.73%52.94M
-423.44%-299.2M
-202.38%-49.61M
83.45%92.51M
-46.82%48.45M
-61.83%50.43M
100.83%91.12M
Other taxs
-174.85%-3.75M
33.84%-1.35M
86.66%-1.36M
77.41%-2.05M
-258.32%-10.22M
-533.52%-9.05M
70.36%-2.85M
71.34%-1.43M
47.77%-9.63M
63.64%-4.99M
Interest received - operating
106.56%63.92M
-60.77%23M
17.70%30.95M
260.65%58.62M
119.16%26.29M
16,655.67%16.25M
-78.64%12M
-98.53%97K
4,353.13%56.15M
2,874.32%6.6M
Interest paid - operating
-32.50%-29.46M
-22.72%-17.54M
-141.13%-22.24M
-356.68%-14.29M
38.91%-9.22M
54.59%-3.13M
-2.03%-15.09M
---6.89M
47.65%-14.79M
----
Net cash from operations
-69.88%95.34M
-117.00%-16.19M
208.26%316.49M
309.11%95.22M
-437.76%-292.35M
-213.19%-45.54M
5.35%86.56M
-56.62%40.23M
-5.21%82.16M
190.90%92.73M
Cash flow from investment activities
Dividend received - investment
-75.95%707K
----
--2.94M
--2.94M
----
----
--13.65M
--13.65M
----
----
Loan receivable (increase) decrease
-113.14%-170.42M
-181.45%-17.87M
-751.86%-79.96M
131.90%21.94M
95.69%-9.39M
14.01%-68.8M
-1,374.56%-217.76M
-134.36%-80M
103.46%17.09M
288.15%232.85M
Sale of fixed assets
----
--25K
72.26%236K
----
--137K
--356K
----
----
----
----
Purchase of fixed assets
10.81%-6.21M
45.85%-3.32M
50.60%-6.96M
-26.81%-6.14M
-156.25%-14.09M
-482.89%-4.84M
9.36%-5.5M
-6.41%-830K
0.61%-6.07M
87.66%-780K
Purchase of intangible assets
----
----
----
----
----
----
----
----
----
---258.71M
Sale of subsidiaries
----
----
---909K
---909K
----
----
----
--6.84M
----
----
Recovery of cash from investments
--3.73M
----
----
----
----
----
----
--1.04M
----
----
Cash on investment
54.24%-45.76M
---217K
-203.03%-100M
----
---33M
----
----
----
----
----
Other items in the investment business
----
----
----
----
----
---104.07M
--1.04M
----
----
101.85%4.18M
Net cash from investment operations
-18.03%-217.95M
-219.88%-21.39M
-227.73%-184.65M
110.06%17.84M
72.99%-56.34M
-199.06%-177.35M
-1,993.18%-208.57M
-164.02%-59.3M
102.50%11.02M
93.68%-22.46M
Net cash before financing
-193.00%-122.61M
-133.24%-37.58M
137.81%131.83M
150.73%113.06M
-185.77%-348.69M
-1,068.59%-222.89M
-230.95%-122.02M
-127.14%-19.07M
126.37%93.18M
121.72%70.27M
Cash flow from financing activities
New borrowing
-32.88%304.11M
-34.76%51.71M
-1.74%453.09M
-60.72%79.26M
301.53%461.12M
272.48%201.77M
-71.74%114.84M
-62.14%54.17M
-7.02%406.39M
-47.70%143.08M
Refund
-6.03%-503.91M
-11.45%-143.25M
1.57%-475.26M
63.98%-128.53M
-213.36%-482.83M
-761.48%-356.85M
81.39%-154.08M
92.38%-41.42M
-54.98%-828.07M
-114.29%-543.84M
Issuing shares
----
----
-70.80%99.01M
-70.80%99.01M
101.41%339.11M
--339.11M
--168.37M
----
----
----
Issuance expenses and redemption of securities expenses
----
----
-2,799.71%-108.51M
-4,142.65%-158.76M
-174.94%-3.74M
---3.74M
---1.36M
----
----
----
Other items of the financing business
--448K
----
----
----
----
----
----
----
----
----
Net cash from financing operations
400.02%98.72M
44.18%-61.07M
-110.54%-32.9M
-160.80%-109.41M
145.43%312.21M
1,311.81%179.94M
222.16%127.21M
115.33%12.75M
-6.89%-104.13M
-519.23%-83.13M
Effect of rate
-204.73%-1.13M
14.38%-673K
988.89%1.08M
-107.17%-786K
111.48%99K
228.72%10.96M
-5,170.59%-862K
-1,154.65%-8.51M
-26.09%17K
74.68%807K
Net Cash
-124.15%-23.89M
-2,799.75%-98.65M
371.13%98.93M
108.51%3.65M
-802.91%-36.49M
-578.75%-42.95M
147.40%5.19M
50.79%-6.33M
97.57%-10.95M
95.77%-12.86M
Begining period cash
459.64%121.77M
459.64%121.77M
-62.58%21.76M
-62.58%21.76M
8.04%58.15M
8.04%58.15M
-16.89%53.82M
-16.89%53.82M
-87.44%64.75M
-85.71%64.75M
Cash at the end
-20.55%96.75M
-8.86%22.45M
459.64%121.77M
-5.83%24.63M
-62.58%21.76M
-32.91%26.15M
8.04%58.15M
-26.03%38.98M
-16.89%53.82M
-64.86%52.7M
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax 116.42%93.99M-----65.02%-572.46M-----257.21%-346.91M-----267.81%-97.12M----66.67%57.87M----
Profit adjustment
Interest (income) - adjustment -19.36%-37.33M----16.58%-31.27M-----6.49%-37.49M----37.31%-35.2M-----4,353.13%-56.15M----
Dividend (income)- adjustment ---707K------------------------------------
Investment loss (gain) -99.46%2.56M----80.19%471.04M----2,344.44%261.41M----133,775.00%10.69M-----100.38%-8K----
Impairment and provisions: -89.67%5.04M----30.39%48.74M-----58.14%37.38M----62.80%89.29M----444.57%54.85M----
-Impairmen of inventory (reversal) --------131.88%1.01M-----35.41%436K----10.29%675K----551.06%612K----
-Other impairments and provisions -89.45%5.04M----29.19%47.73M-----58.31%36.94M----63.39%88.62M----438.72%54.24M----
Revaluation surplus: ---764K---------------------78.98%2M----1,273.49%9.52M----
-Derivative financial instruments fair value (increase) --8.44M------------------------------------
-Other fair value changes ---9.2M---------------------78.98%2M----1,273.49%9.52M----
Asset sale loss (gain): 100.15%25K-----13,096.85%-16.76M----92.87%-127K----80.58%-1.78M----26.05%-9.17M----
-Loss (gain) from sale of subsidiary company -----------16.52M---------------1.78M------------
-Loss (gain) on sale of property, machinery and equipment 110.59%25K-----85.83%-236K-------127K-------------73.03%24K----
-Loss (gain) from selling other assets --------------------------------26.38%-9.19M----
Depreciation and amortization: -8.91%32.91M-----38.81%36.13M-----1.61%59.04M-----16.61%60.01M-----13.08%71.96M----
-Amortization of intangible assets 0.06%3.2M-----0.47%3.2M-----0.59%3.21M-----75.47%3.23M-----40.48%13.17M----
Financial expense 15.21%40.42M-----11.42%35.08M----5.22%39.6M----5.57%37.64M-----21.43%35.66M----
Exchange Loss (gain) -231.03%-11.25M------8.59M----------------------------
Special items --20.12M----------------------43K------------
Operating profit before the change of operating capital 718.71%144.1M-----321.22%-23.29M-----83.34%10.53M-----61.02%63.2M----22.63%162.15M----
Change of operating capital
Inventory (increase) decrease -123.22%-10.53M----458.91%45.32M----24.03%-12.63M----46.27%-16.62M-----304.72%-30.94M----
Accounts receivable (increase)decrease -1,917.49%-78.26M----128.55%4.31M----32.92%-15.08M----54.92%-22.49M-----764.60%-49.88M----
Accounts payable increase (decrease) 107.87%50.73M----120.13%24.4M-----480.34%-121.24M-----110.18%-20.89M----1,608.10%205.21M----
prepayments (increase)decrease -35.62%49.79M----208.67%77.35M-----165.02%-71.18M----128.30%109.47M-----1,080.44%-386.84M----
Special items for working capital changes -150.38%-91.2M----302.07%181.05M-----344.18%-89.6M-----113.38%-20.17M----1,300.56%150.73M----
Cash  from business operations -79.09%64.63M-138.32%-20.29M203.32%309.14M206.73%52.94M-423.44%-299.2M-202.38%-49.61M83.45%92.51M-46.82%48.45M-61.83%50.43M100.83%91.12M
Other taxs -174.85%-3.75M33.84%-1.35M86.66%-1.36M77.41%-2.05M-258.32%-10.22M-533.52%-9.05M70.36%-2.85M71.34%-1.43M47.77%-9.63M63.64%-4.99M
Interest received - operating 106.56%63.92M-60.77%23M17.70%30.95M260.65%58.62M119.16%26.29M16,655.67%16.25M-78.64%12M-98.53%97K4,353.13%56.15M2,874.32%6.6M
Interest paid - operating -32.50%-29.46M-22.72%-17.54M-141.13%-22.24M-356.68%-14.29M38.91%-9.22M54.59%-3.13M-2.03%-15.09M---6.89M47.65%-14.79M----
Net cash from operations -69.88%95.34M-117.00%-16.19M208.26%316.49M309.11%95.22M-437.76%-292.35M-213.19%-45.54M5.35%86.56M-56.62%40.23M-5.21%82.16M190.90%92.73M
Cash flow from investment activities
Dividend received - investment -75.95%707K------2.94M--2.94M----------13.65M--13.65M--------
Loan receivable (increase) decrease -113.14%-170.42M-181.45%-17.87M-751.86%-79.96M131.90%21.94M95.69%-9.39M14.01%-68.8M-1,374.56%-217.76M-134.36%-80M103.46%17.09M288.15%232.85M
Sale of fixed assets ------25K72.26%236K------137K--356K----------------
Purchase of fixed assets 10.81%-6.21M45.85%-3.32M50.60%-6.96M-26.81%-6.14M-156.25%-14.09M-482.89%-4.84M9.36%-5.5M-6.41%-830K0.61%-6.07M87.66%-780K
Purchase of intangible assets ---------------------------------------258.71M
Sale of subsidiaries -----------909K---909K--------------6.84M--------
Recovery of cash from investments --3.73M--------------------------1.04M--------
Cash on investment 54.24%-45.76M---217K-203.03%-100M-------33M--------------------
Other items in the investment business -----------------------104.07M--1.04M--------101.85%4.18M
Net cash from investment operations -18.03%-217.95M-219.88%-21.39M-227.73%-184.65M110.06%17.84M72.99%-56.34M-199.06%-177.35M-1,993.18%-208.57M-164.02%-59.3M102.50%11.02M93.68%-22.46M
Net cash before financing -193.00%-122.61M-133.24%-37.58M137.81%131.83M150.73%113.06M-185.77%-348.69M-1,068.59%-222.89M-230.95%-122.02M-127.14%-19.07M126.37%93.18M121.72%70.27M
Cash flow from financing activities
New borrowing -32.88%304.11M-34.76%51.71M-1.74%453.09M-60.72%79.26M301.53%461.12M272.48%201.77M-71.74%114.84M-62.14%54.17M-7.02%406.39M-47.70%143.08M
Refund -6.03%-503.91M-11.45%-143.25M1.57%-475.26M63.98%-128.53M-213.36%-482.83M-761.48%-356.85M81.39%-154.08M92.38%-41.42M-54.98%-828.07M-114.29%-543.84M
Issuing shares ---------70.80%99.01M-70.80%99.01M101.41%339.11M--339.11M--168.37M------------
Issuance expenses and redemption of securities expenses ---------2,799.71%-108.51M-4,142.65%-158.76M-174.94%-3.74M---3.74M---1.36M------------
Other items of the financing business --448K------------------------------------
Net cash from financing operations 400.02%98.72M44.18%-61.07M-110.54%-32.9M-160.80%-109.41M145.43%312.21M1,311.81%179.94M222.16%127.21M115.33%12.75M-6.89%-104.13M-519.23%-83.13M
Effect of rate -204.73%-1.13M14.38%-673K988.89%1.08M-107.17%-786K111.48%99K228.72%10.96M-5,170.59%-862K-1,154.65%-8.51M-26.09%17K74.68%807K
Net Cash -124.15%-23.89M-2,799.75%-98.65M371.13%98.93M108.51%3.65M-802.91%-36.49M-578.75%-42.95M147.40%5.19M50.79%-6.33M97.57%-10.95M95.77%-12.86M
Begining period cash 459.64%121.77M459.64%121.77M-62.58%21.76M-62.58%21.76M8.04%58.15M8.04%58.15M-16.89%53.82M-16.89%53.82M-87.44%64.75M-85.71%64.75M
Cash at the end -20.55%96.75M-8.86%22.45M459.64%121.77M-5.83%24.63M-62.58%21.76M-32.91%26.15M8.04%58.15M-26.03%38.98M-16.89%53.82M-64.86%52.7M
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More